|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.155 CAD | 0.00% |
|
0.00% | +55.00% |
| Apr. 18 | Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding | CI |
| Apr. 11 | Entheon Biomedical Corp. announced that it expects to receive CAD 0.1475 million in funding | CI |
Entheon Biomedical Corp. announced that it has closed patient enrolment in its clinical research study EBIQ-101. The company announced the closing of patient enrolment in its EBIQ-101 Study being conducted at Heading Health.
Entheon expects to commence the process of concluding the study in cooperation with its vendors and partners in the coming weeks.
| 1st Jan change | Capi. | |
|---|---|---|
| +55.00% | 1M | |
| +1.12% | 42.59B | |
| +6.77% | 40.65B | |
| +47.98% | 40.57B | |
| -11.96% | 26.77B | |
| +6.01% | 24.81B | |
| -24.92% | 18.17B | |
| +27.16% | 12.05B | |
| -3.63% | 11.7B | |
| +7.30% | 11.1B |
ENTHEON BIOMEDICAL CORP. 
